Ralph Ciccone
Pulmonary Disease · Staten Island, NYNPI 1427007905
Payments from drug & device makers
Across 629 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Jazz Pharmaceuticals Inc.$787
- Boehringer Ingelheim$684
- Sunovion Pharmaceuticals Inc.$606
- Mylan Specialty L.p.$531
- plus $4K from 30 others
What the payments were for
- Food & beverage$10,776100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 137 | $2,392 |
| AstraZeneca | 99 | $2,108 |
| Jazz Pharmaceuticals Inc. | 62 | $787 |
| Boehringer Ingelheim | 41 | $684 |
| Sunovion Pharmaceuticals Inc. | 36 | $606 |
| Mylan Specialty L.p. | 30 | $531 |
| Sanofi | 22 | $521 |
| Insmed, Inc. | 23 | $327 |
| Novartis | 18 | $294 |
| Regeneron Healthcare Solutions, Inc. | 16 | $285 |
| Electromed, Inc. | 21 | $279 |
| Philips North America LLC | 17 | $248 |
| Teva Pharmaceuticals USA, Inc. | 7 | $215 |
| E.r. Squibb & Sons, L.L.C. | 15 | $203 |
| Grifols USA, LLC | 13 | $180 |
| Genentech USA, Inc. | 11 | $132 |
| Optinose US, Inc. | 2 | $117 |
| Harmony Biosciences LLC | 7 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $107 |
| Vanda Pharmaceuticals Inc. | 7 | $97 |
| Johnson & Johnson | 6 | $88 |
| Merck | 6 | $81 |
| Mallinckrodt Enterprises LLC | 5 | $69 |
| Shire North American Group Inc | 4 | $55 |
| Amgen | 3 | $40 |
| Resmed Corp | 2 | $31 |
| Eisai Inc. | 2 | $29 |
| United Therapeutics Corporation | 2 | $28 |
| Vapotherm Inc | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Covis Pharma GmbH | 1 | $18 |
| Gilead | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Pfizer | 1 | $13 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$474
- FASENRA$450
- NUCALA$272
- ArmonAir Digihaler$135
- ProAir Digihaler$135
- AirDuo RespiClick$135
- OFEV$125
- FARXIGA$116
- BREZTRI$116
- Xhance$108
- DUPIXENT$102
How this compares
$10,776 in reported general payments places this provider in the 80th percentile of 1,115 pulmonary disease providers in New York.
Other pulmonary disease in Staten Island
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- R WhiteRochester$3.1M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Robert KanerNew York$2.3M
- Negin HajizadehGreenport$2M
- Doreen Addrizzo-HarrisNew York$1.9M
- Sherif El BayadiSyracuse$1.9M
- Daniel LachantRochester$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.